| Sign In to gain access to subscriptions and/or personal tools. |
Prospective evaluation of diabetic ischaemic heart disease by computed tomography: the PREDICT studyUnit for Metabolic Medicine, Faculty of Medicine, Imperial College, robert.elkeles{at}st-marys.nhs.uk
Clinical Trials and Evaluation Unit
Beta Cell Unit, Chelsea and Westminster Hospital, 269 Fulham Road, London SW10 9NH
Unit for Metabolic Medicine, Faculty of Medicine, Imperial College
Department of Chemical Pathology, St Mary's Hospital, Praed Street, London, W2 1NY
Division of Cardiovascular Genetics, Rayne Institute, University College London, 5 University Street, London, WC1E 6JJ
Department of Imaging, Royal Brompton Hospital
Department of Cardiac Imaging, Royal Brompton Hospital, Sydney Street, London SW3 6NP Coronary heart disease (CHD) is the main cause of morbidity and mortality in type 2 diabetic subjects. Electron beam computed tomography (EBCT) of the coronary arteries provides a non-invasive method of detecting and quantifying coronary calcification (coronary calcium score), which is known to be an early marker of coronary atheroma in non-diabetic subjects. 600 type 2 diabetic subjects aged between 50 and 70 years of either sex will undergo EBCT. They will be followed-up for a mean period of four years. Recruitment started in September 2000 and preliminary results are expected in 2004. The primary aim is to assess the predictive power of the coronary calcium score for coronary events specifically in type 2 diabetic subjects. Secondary aims are to assess the relationship between coronary calcium score in type 2 diabetes and conventional risk factors, with novel risk markers, plasma homocysteine and C-reactive protein, and with key genetic markers of CHD.
Key Words: type 2 diabetes electron beam computed tomography coronary heart disease.
The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 1,
69-72a (2002) |
|||